Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamitsu Hara

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|July 30, 2013
A framework for analysis of abortive colony size distributions using a model of branching processes in irradiated normal human fibroblastsTetsuya Sakashita, Nobuyuki Hamada, Isao Kawaguchi, et al.
Journal of Radiation Research|December 5, 2009
The suppression of hypoxia-inducible factor and vascular endothelial growth factor by siRNA does not affect the radiation sensitivity of multicellular tumor spheroidsYuefen Zou, Chao Cheng, Motoko Omura-Minamisawa, et al.
Cancer Letters|January 21, 2004
Glutathione S-transferase P1 has protective effects on cell viability against camptothecinTakamitsu Hara, Takeo Ishii, Mina Fujishiro, et al.
Cancer Letters|May 3, 2008
The survival of heavy ion-irradiated Bcl-2 overexpressing radioresistant tumor cells and their progenyNobuyuki Hamada, Takamitsu Hara, Motoko Omura-Minamisawa, et al.
Annals of Nuclear Medicine|December 18, 2015
Comparison of integrated whole-body PET/MR and PET/CT: Is PET/MR alternative to PET/CT in routine clinical oncology?Shirou Ishii, Daisuke Shimao, Takamitsu Hara, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2008
Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2Nobuyuki Hamada, Takamitsu Hara, Motoko Omura-Minamisawa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2008
The small-molecule Bcl-2 inhibitor HA14-1 sensitizes cervical cancer cells, but not normal fibroblasts, to heavy-ion radiationNobuyuki Hamada, Keiko Kataoka, Sakura Sora, et al.
The Journal of Veterinary Medical Science|July 6, 2007
Vulnerability of feline T-lymphocytes to charged particlesTakehiko Kakizaki, Nobuyuki Hamada, Tetsuya Sakashita, et al.
Japanese Journal of Radiology|October 8, 2016
Optimized workflow and imaging protocols for whole-body oncologic PET/MRIShirou Ishii, Takamitsu Hara, Takeyuki Nanbu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|July 30, 2013
A framework for analysis of abortive colony size distributions using a model of branching processes in irradiated normal human fibroblastsTetsuya Sakashita, Nobuyuki Hamada, Isao Kawaguchi, et al.
Journal of Radiation Research|December 5, 2009
The suppression of hypoxia-inducible factor and vascular endothelial growth factor by siRNA does not affect the radiation sensitivity of multicellular tumor spheroidsYuefen Zou, Chao Cheng, Motoko Omura-Minamisawa, et al.
Cancer Letters|January 21, 2004
Glutathione S-transferase P1 has protective effects on cell viability against camptothecinTakamitsu Hara, Takeo Ishii, Mina Fujishiro, et al.
Cancer Letters|May 3, 2008
The survival of heavy ion-irradiated Bcl-2 overexpressing radioresistant tumor cells and their progenyNobuyuki Hamada, Takamitsu Hara, Motoko Omura-Minamisawa, et al.
Annals of Nuclear Medicine|December 18, 2015
Comparison of integrated whole-body PET/MR and PET/CT: Is PET/MR alternative to PET/CT in routine clinical oncology?Shirou Ishii, Daisuke Shimao, Takamitsu Hara, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2008
Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2Nobuyuki Hamada, Takamitsu Hara, Motoko Omura-Minamisawa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2008
The small-molecule Bcl-2 inhibitor HA14-1 sensitizes cervical cancer cells, but not normal fibroblasts, to heavy-ion radiationNobuyuki Hamada, Keiko Kataoka, Sakura Sora, et al.
The Journal of Veterinary Medical Science|July 6, 2007
Vulnerability of feline T-lymphocytes to charged particlesTakehiko Kakizaki, Nobuyuki Hamada, Tetsuya Sakashita, et al.
Japanese Journal of Radiology|October 8, 2016
Optimized workflow and imaging protocols for whole-body oncologic PET/MRIShirou Ishii, Takamitsu Hara, Takeyuki Nanbu, et al.
Pageof 2